These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2765156)
1. [Biotransformation in patients following Depressan-induced hepatitis]. Hoffmann A; Reinhardt M; Rechenbach C; Henschel L; Jorke D Gastroenterol J; 1989; 49(1):8-11. PubMed ID: 2765156 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of antipyrine and sulfamethazine in patients recovered from dihydralazine-hepatitis. Siegmund W; Franke G; Baumgarten R; Fengler JD; Krüger R; Reichardt R Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):165-9. PubMed ID: 2714917 [TBL] [Abstract][Full Text] [Related]
3. [Resorption and biotransformation of model substances in primary idiopathic hemochromatosis (siderophilia)]. Hoffmann A; Müller A; Reinhardt M; Truckenbrodt J; Jorke D Gastroenterol J; 1989; 49(3):113-7. PubMed ID: 2629779 [TBL] [Abstract][Full Text] [Related]
4. [Morphology and pathogenesis of liver injury produced by dihydralazine , propranolol and ketophenylbutazone]. Kunze KD; Porst H; Tschöpel L Zentralbl Allg Pathol; 1985; 130(6):509-18. PubMed ID: 3841742 [TBL] [Abstract][Full Text] [Related]
5. [Chronic drug-induced hepatitis caused by dihydralazine]. Roschlau G; Hass S; Schmehl V Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):41-6. PubMed ID: 3371237 [TBL] [Abstract][Full Text] [Related]
6. [Drug-induced hepatitis after dihydralazine treatment with fatal consequences]. Machnik G; Bergert A; Justus J; Kunze P; Müller R; Reinhardt M; Schulz H; Stein G; Thiele R Zentralbl Allg Pathol; 1988; 134(2):167-77. PubMed ID: 3420978 [TBL] [Abstract][Full Text] [Related]
7. The influence of the acetylator phenotype for the clinical use of dihydralazine. Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694 [TBL] [Abstract][Full Text] [Related]
13. [Liver lesions induced by dihydralazine and propranolol]. Kunze KD; Porst H; Lohmann J; Tschöpel L Zentralbl Allg Pathol; 1985; 130(1):19-29. PubMed ID: 3984541 [TBL] [Abstract][Full Text] [Related]
14. [Dihydralazine-induced hepatitis with bridging necrosis. A clinico-pathologic survey of 20 cases]. Roschlau G Zentralbl Allg Pathol; 1983; 127(5-6):385-93. PubMed ID: 6880446 [TBL] [Abstract][Full Text] [Related]
15. [Acute liver damage in patients treated with a depressant (dihydralazine sulfate)]. László B; Kendrey G Orv Hetil; 1981 Dec; 122(52):3197-200. PubMed ID: 7329695 [No Abstract] [Full Text] [Related]
16. Dihydralazine therapy and acetylator phenotype. Iisalo E; Laine T; Lehtonen A; Sellman R Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082 [TBL] [Abstract][Full Text] [Related]
17. [Morphologic observations in liver damage in patients taking Depressan (dihydralazinum sulfuricum)]. Kendrey G; László B Morphol Igazsagugyi Orv Sz; 1981 Oct; 21(4):283-8. PubMed ID: 7322182 [TBL] [Abstract][Full Text] [Related]
18. [Drug-induced hepatitis in a diabetic patient]. Kantola I; Viikari J; Leino R; Seppälä P Duodecim; 1985; 101(6):587-90. PubMed ID: 3987570 [No Abstract] [Full Text] [Related]
19. [Dihydralazine hepatitis]. Colombel JF; Cortot A; Houcke M; Prin L; Dessaint JP; Gerard A; Paris JC Presse Med; 1985 Mar; 14(9):552. PubMed ID: 3157181 [No Abstract] [Full Text] [Related]
20. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects. Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]